BioSpace News Archive

Business

European Medicines Agency Scales Back In Preparation for Brexit

As Britain’s “Brexit” from the European Union moves closer and closer, the European Medicines Agency (EMA), the equivalent to the U.S. Food and Drug Administration (FDA), temporary halted some of its activities in preparation.

August 2, 2018
·
2 min read
·
Mark Terry
Business

Particle Sciences Receives Patent for Device to Deliver Medication to the Tympanic Membrane

The Lubrizol Corporation announces its LifeSciences and Particle Sciences businesses, have received a Notice of Allowance on a device for the delivery of medication to the ear-drum.

August 2, 2018
·
3 min read
BioCapital

Advantia Health Benefits Patients by Expanding into Clinical Research

Advantia Health is expanding into clinical research.

August 2, 2018
·
2 min read
Policy

Intel Applauds Bipartisan Congressional Effort to Accelerate Quantum Computing Research

This week, the U.S. Senate is reviewing its version of the National Quantum Initiative Act (S. 3143), a bipartisan bill to create a 10-year coordinated federal program to accelerate quantum research and development for the economic and national security of the United States.

August 2, 2018
·
2 min read
Business

Conisus, a leading provider of hematology and oncology brand strategy, business intelligence, and educational programming

In the first half of 2018, Conisus, a strategic marketing and medical communications agency focused on brand strategy, business intelligence (BI), and peer-to-peer programming, announced several important accomplishments.

August 2, 2018
·
4 min read
Genetown

Autism Google Glass Crowdfunding Campaign Ships Groundbreaking Technology On Time

Brain Power, a Boston-based neurotechnology company, shipped the first 60 units of its award-winning Empowered Brain™ smartglasses on time, and will ship successive rounds of orders ahead of schedule.

August 2, 2018
·
2 min read
FDA

Hologic Announces FDA Clearance of the Panther Fusion® GBS Assay

System’s Latest Assay Increases Lab Efficiency and Flexibility With Highly Sensitive and Specific Detection

August 2, 2018
·
4 min read
Business

AcelRx Pharmaceuticals Reports Second Quarter 2018 Financial Results

European Commission approved DZUVEO (sufentanil sublingual tablet, 30 mcg) for the management of acute moderate-to-severe pain in adults in medically monitored settings

August 2, 2018
·
13 min read
Business

Varex Announces Financial Results For Third Quarter Of Fiscal Year 2018

Varex Imaging Corporation announced its financial results for the third quarter of fiscal year 2018, as well as certain integration-related restructuring charges.

August 2, 2018
·
29 min read
Deals

PDL BioPharma Acquires Depomed’s Remaining 50% Interest in Royalties and Milestones on Type 2 Diabetes Products

PDL BioPharma, Inc. announces an amendment to the Royalty Purchase and Sale Agreement with Depomed, Inc. under which PDL acquired all of Depomed’s remaining rights to royalties and milestones payable on sales of type 2 diabetes products licensed by Depomed for up to $20 million.

August 2, 2018
·
3 min read